MaxCyte MXCT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$39.12M+12.3% | -$44.63M+2.2% | -$45.63M-1.9% | -$44.77M-7.1% | -$41.79M-1.8% | ||
| $4.29M-1.1% | $4.34M+0.3% | $4.33M+0.1% | $4.32M+0.4% | $4.3M-0.3% | ||
| $7.32M-20.6% | $9.21M-20.9% | $11.64M-10.8% | $13.06M-0.4% | $13.11M+0.2% | ||
| -$28.17M+18.1% | -$34.41M+13.0% | -$39.54M-8.4% | -$36.48M-16.0% | -$31.46M-13.9% | ||
| $1.19M-32.9% | $1.77M+5.0% | $1.68M-5.9% | $1.79M+19.3% | $1.5M-9.1% | ||
| —— | —— | —— | —— | —— | ||
| $19.06M-26.5% | $25.94M— | —— | —— | —— | ||
| $278K-57.6% | $656K-31.9% | $963K-18.2% | $1.18M-32.2% | $1.74M-15.6% | ||
| —— | —— | -$23.99M-7.6% | -$22.29M— | —— | ||
| -$29.36M+18.9% | -$36.18M+12.2% | -$41.23M-7.7% | -$38.27M-16.1% | -$32.96M-12.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MaxCyte generate?
- MaxCyte (MXCT) generated -$28.2M in operating cash flow over the trailing twelve months.
- What is MaxCyte's free cash flow?
- After $1.2M of capital expenditures, MaxCyte's free cash flow was -$29.4M over the trailing twelve months, up 10.9% year over year.
- Where does MaxCyte's cash flow data come from?
- Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
